Coreline Soft plans to introduce its chest AI platform at RSNA 2025.
Called AVIEW 2.0, the system combines lung-cancer screening (LCS), coronary-artery calcium (CAC) scoring, and chronic obstructive pulmonary disease (COPD) quantification into a single, continuous analytical pipeline, according to the firm.
The company highlighted "national-scale validation" in Europe. In addition, UMass Memorial Medical Center has deployed the system for LCS, CAC, and COPD diagnosis, the company noted, adding that Temple Lung Center, 3DR Labs, and ImageCare Radiology have incorporated AVIEW into their research and diagnostic environments, each adapting AI functions to site-specific workflows and physician preferences.
At RSNA 2025, Coreline will conduct an end-to-end AI workflow demonstration in the "Radiology Reimagined" demo zone. The meeting will take place from Sunday, November 30, through Thursday, December 4.
